Hua Shun, Cao Peiyi, Zhang Guanji, Li Guanglan, Jiang Simin, Xu Yiping, Li Jianbo, Yu Jianwen, Huang Naya, Lin Jianxiong, Yang Xiao, Chen Wei, Mao Haiping, Zhong Zhong
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, 58th, Zhongshan Road II, Guangzhou, 510080, Guangdong, PR China.
NHC Key Laboratory of Clinical Nephrology, Guangdong Provincial Key Laboratory of Nephrology, Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China.
BMC Nephrol. 2025 Jan 25;26(1):41. doi: 10.1186/s12882-025-03962-2.
The high prevalence and prolonged duration of inflow pain and drain pain experienced by peritoneal dialysis (PD) patients following PD catheter implantation impact their quality of life. However, there is limited data on the frequency and predisposing factors of these pains in the Chinese population undergoing peritoneal dialysis.
This study encompassed individuals who underwent peritoneal dialysis catheter implantation at our institution from September 1, 2023, to March 31, 2024. Patients' experiences of inflow pain and drain pain were evaluated using a questionnaire survey and the visual analog scale (VAS), with pain status followed up via telephone for 3 months post-surgery.
A total of 141 patients were included in this study. Inflow pain occurred at rates of 56.0%, 20.9%, 16.9%, and 17.3% at 1-week, 1-month, 2-month, and 3-month postoperatively, respectively, while drain pain rates were 51.8%, 24.3%, 22.3%, and 19.5% for the same period. Slowing down the infusion rate of dialysate (57.0%) or stopping its drainage (60.3%) proved effective in reducing pain. Logistic regression analysis revealed that age (OR = 0.96, P = 0.02), gender (OR = 0.37, P = 0.03), and the method of PD catheter implantation (OR = 2.37, P = 0.04) were independent factors associated with inflow or drain pain within 1-week postoperatively.
The occurrence of inflow pain and drain pain following peritoneal dialysis catheter implantation is notable. Age, gender, and the method of catheter implantation were identified as independent factors influencing the incidence of inflow or drain pain within the first postoperative week.
腹膜透析（PD）患者在植入PD导管后，流入痛和引流痛的高发生率及持续时间会影响他们的生活质量。然而，关于中国腹膜透析人群中这些疼痛的频率和诱发因素的数据有限。
本研究纳入了2023年9月1日至2024年3月31日在我院接受腹膜透析导管植入的患者。通过问卷调查和视觉模拟量表（VAS）评估患者的流入痛和引流痛体验，并在术后3个月通过电话随访疼痛状况。
本研究共纳入141例患者。术后1周、1个月、2个月和3个月时，流入痛发生率分别为56.0%、20.9%、16.9%和17.3%，同期引流痛发生率分别为51.8%、24.3%、22.3%和19.5%。减慢透析液输注速度（57.0%）或停止引流（60.3%）被证明对减轻疼痛有效。逻辑回归分析显示，年龄（OR = 0.96，P = 0.02）、性别（OR = 0.37，P = 0.03）和PD导管植入方法（OR = 2.37，P = 0.04）是术后1周内与流入痛或引流痛相关的独立因素。
腹膜透析导管植入后流入痛和引流痛的发生较为显著。年龄、性别和导管植入方法被确定为影响术后第一周内流入痛或引流痛发生率的独立因素。
